** Shares of Actinogen Medical Ltd fall as much as 14.3% to A$0.030, their lowest since Aug 26

** The biotechnology firm raises A$11.1 mln ($7.51 mln) via share placement and share purchase plan

** The placement price of A$0.03 per share represents a 14.3% discount to ACW's last closing price

** Co says funds from capital raise will be used to accelerate enrolment and trial of patients with Alzheimer's disease

** ACW stock up 36.4% YTD

($1 = 1.4789 Australian dollars)

(Reporting by Ayushman Ojha in Bengaluru)

((Ayushman.ojha@thomsonreuters.com;))